| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |